Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Angela Dispenzieri

Showing results (251-260 of 904) with videos related to

Pageof 91
Sort By:
Blood|October 11, 2013
How I treat monoclonal gammopathy of renal significance (MGRS)Jean-Paul Fermand, Frank Bridoux, Robert A Kyle, et al.
Blood|October 11, 2012
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificantNelson Leung, Frank Bridoux, Colin A Hutchison, et al.
Journal of Proteome Research|February 21, 2014
Monitoring M-proteins in patients with multiple myeloma using heavy-chain variable region clonotypic peptides and LC-MS/MSDavid R Barnidge, Renee C Tschumper, Jason D Theis, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 10, 2002
A multicenter phase II trial of 4'-iodo-4'deoxydoxorubicin (IDOX) in primary amyloidosis (AL)Morie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Blood Cancer Journal|December 15, 2019
Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurementDavid Murray, Shaji K Kumar, Robert A Kyle, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 7, 2021
Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosisGiovanni Palladini, Stefan O Schönland, Vaishali Sanchorawala, et al.
Leukemia|July 7, 2018
Assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patientsSanjay Kumar, David Murray, Surendra Dasari, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 15, 2023
A novel <i>APOA1</i> frameshift mutation Glu120Glyfs*60 with upper gastrointestinal involvement and an indolent courseEli Muchtar, Surendra Dasari, Jason D Theis, et al.
Mayo Clinic Proceedings|April 17, 2018
Fifty-Year Incidence of Waldenström Macroglobulinemia in Olmsted County, Minnesota, From 1961 Through 2010: A Population-Based Study With Complete Case Capture and Hematopathologic ReviewRobert A Kyle, Dirk R Larson, Ellen D McPhail, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastasesPeter M Anderson, Gregory A Wiseman, Angela Dispenzieri, et al.
Pageof 91

Showing results (251-260 of 904) with videos related to

Sort By:
Pageof 91
Blood|October 11, 2013
How I treat monoclonal gammopathy of renal significance (MGRS)Jean-Paul Fermand, Frank Bridoux, Robert A Kyle, et al.
Blood|October 11, 2012
Monoclonal gammopathy of renal significance: when MGUS is no longer undetermined or insignificantNelson Leung, Frank Bridoux, Colin A Hutchison, et al.
Journal of Proteome Research|February 21, 2014
Monitoring M-proteins in patients with multiple myeloma using heavy-chain variable region clonotypic peptides and LC-MS/MSDavid R Barnidge, Renee C Tschumper, Jason D Theis, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|May 10, 2002
A multicenter phase II trial of 4'-iodo-4'deoxydoxorubicin (IDOX) in primary amyloidosis (AL)Morie A Gertz, Martha Q Lacy, Angela Dispenzieri, et al.
Blood Cancer Journal|December 15, 2019
Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurementDavid Murray, Shaji K Kumar, Robert A Kyle, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|January 7, 2021
Clarification on the definition of complete haematologic response in light-chain (AL) amyloidosisGiovanni Palladini, Stefan O Schönland, Vaishali Sanchorawala, et al.
Leukemia|July 7, 2018
Assay to rapidly screen for immunoglobulin light chain glycosylation: a potential path to earlier AL diagnosis for a subset of patientsSanjay Kumar, David Murray, Surendra Dasari, et al.
Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis|March 15, 2023
A novel <i>APOA1</i> frameshift mutation Glu120Glyfs*60 with upper gastrointestinal involvement and an indolent courseEli Muchtar, Surendra Dasari, Jason D Theis, et al.
Mayo Clinic Proceedings|April 17, 2018
Fifty-Year Incidence of Waldenström Macroglobulinemia in Olmsted County, Minnesota, From 1961 Through 2010: A Population-Based Study With Complete Case Capture and Hematopathologic ReviewRobert A Kyle, Dirk R Larson, Ellen D McPhail, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|January 5, 2002
High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastasesPeter M Anderson, Gregory A Wiseman, Angela Dispenzieri, et al.
Pageof 91